Translational and clinical studies have demonstrated that the inhibition of HIF-1α diminishes antioxidant activity and tumor angiogenesis, modifies the TME, and increases radiosensitivity in solid tumors [19]. The gene discussed is HIF1A; the disease is neoplasm.